Divi's Laboratories (DIVISLAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE361B01024
Key metrics
- Market Cap
- ₹2.43 L Cr
- P/E Ratio
- 82.97
- EPS
- 110.21
- Book Value
- 631.37
- P/B Ratio
- 14.3
- ROE
- 15.32%
- ROCE
- 17.77%
- Debt / Equity
- 0
- Net Margin
- 24.51%
- Revenue Growth
- 12.34%
- Profit Growth
- 17.21%
- Dividend Yield
- 0.33%
- 52W High
- ₹9,740.00
- 52W Low
- ₹5,647.50
- Market Cap Band
- large cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Divi's Laboratories Limited
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 11,565
- Promoter Holding
- 52%
Divi's Laboratories and the Drug Manufacturers - Specialty & Generic industry
Divi's Laboratories is one of 153 listed companies in the Drug Manufacturers - Specialty & Generic industry. At a P/E of 83.0, it trades above the industry median of 30.6.
All Drug Manufacturers - Specialty & Generic stocks →Healthcare sector stocks →
Related companies
- Sun Pharmaceutical IndustriesSUNPHARMA · ₹1,746.50₹4.22 L Cr
- Torrent PharmaceuticalsTORNTPHARM · ₹4,563.80₹1.74 L Cr
- Zydus LifesciencesZYDUSLIFE · ₹1,121.00₹1.12 L Cr
- Laurus LabsLAURUSLABS · ₹2,068.70₹1.11 L Cr
- CiplaCIPLA · ₹1,328.50₹1.07 L Cr
- Dr. Reddy's LaboratoriesDRREDDY · ₹1,233.50₹1.03 L Cr
- Aurobindo PharmaAUROPHARMA · ₹1,644.70₹95,910 Cr
- Mankind PharmaMANKIND · ₹2,271.60₹93,988 Cr
Divi's Laboratories: key questions
What does Divi's Laboratories do?
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
What is the share price of Divi's Laboratories?
Divi's Laboratories (DIVISLAB) last traded at ₹9,175.50 on the NSE, up 0.3% on the day. Over the past 52 weeks it has traded between ₹5,647.50 and ₹9,740.00. The current price is 5.8% below its 52-week high.
What is the market cap of Divi's Laboratories?
Divi's Laboratories has a market capitalisation of ₹2.43 L Cr, which makes it a large-cap company. It is the 2nd largest of 153 listed companies in the Drug Manufacturers - Specialty & Generic industry by market capitalisation.
What is the P/E ratio of Divi's Laboratories?
Divi's Laboratories trades at a price-to-earnings (P/E) ratio of 83.0. The median P/E across profitable companies in the Drug Manufacturers - Specialty & Generic industry is 30.6.
What are Divi's Laboratories's ROE and ROCE?
For the financial year ended March 2026, Divi's Laboratories reported a return on equity (ROE) of 15.3%, a return on capital employed (ROCE) of 17.8% and a net profit margin of 24.5%.
How fast is Divi's Laboratories growing?
In the financial year ended March 2026, Divi's Laboratories's revenue grew 12.3% and net profit grew 17.2% compared with the previous year.
Does Divi's Laboratories have debt?
Divi's Laboratories reported negligible borrowings, with a debt-to-equity ratio of 0.00.
Does Divi's Laboratories pay a dividend?
Divi's Laboratories has a dividend yield of 0.33% at the current share price.
What is the promoter holding in Divi's Laboratories?
Promoters hold 52.0% of Divi's Laboratories. Institutional investors hold 29.2%.
Which companies are similar to Divi's Laboratories?
Listed companies close to Divi's Laboratories in size within the Drug Manufacturers - Specialty & Generic industry include Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs, Cipla and Dr. Reddy's Laboratories.
Figures are for information only and are not investment advice.
The full Divi's Laboratories analysis
Create a free account to open the complete DIVISLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.